WVE Wave Life Sciences Ltd

  1. Stocks
  2. Healthcare
  3. NASDAQ: WVE

Price (delayed)

$6.14

Market cap

$750.82M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.54

Enterprise value

$582.59M

Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using ...

Highlights
The equity has soared by 198% from the previous quarter and by 188% YoY
Wave Life Sciences's EPS has soared by 74% YoY and by 36% from the previous quarter
The quick ratio fell by 19% QoQ and by 4% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.wavelifesciences.com
Peers: OMER OMGA

Key stats

What are the main financial stats of WVE
Market
Shares outstanding
122.28M
Market cap
$750.82M
Enterprise value
$582.59M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
15.35
Price to sales (P/S)
5.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.14
Earnings
Revenue
$113.31M
EBIT
-$58.19M
EBITDA
-$48.98M
Free cash flow
-$20.55M
Per share
EPS
-$0.54
Free cash flow per share
-$0.19
Book value per share
$0.4
Revenue per share
$1.07
TBVPS
$2.59
Balance sheet
Total assets
$274.95M
Total liabilities
$227.45M
Debt
$32.12M
Equity
$39.63M
Working capital
$48.93M
Liquidity
Debt to equity
0.81
Current ratio
1.26
Quick ratio
1.19
Net debt/EBITDA
3.43
Margins
EBITDA margin
-43.2%
Gross margin
100%
Net margin
-50.8%
Operating margin
-60%
Efficiency
Return on assets
-23.7%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-65.7%
Return on sales
-51.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

WVE stock price

How has the Wave Life Sciences stock price performed over time
Intraday
4.42%
1 week
31.76%
1 month
3.37%
1 year
63.73%
YTD
21.58%
QTD
-0.49%

Financial performance

How have Wave Life Sciences's revenue and profit performed over time
Revenue
$113.31M
Gross profit
$113.31M
Operating income
-$68M
Net income
-$57.51M
Gross margin
100%
Net margin
-50.8%
The operating margin has soared by 99% YoY and by 45% from the previous quarter
Wave Life Sciences's net margin has surged by 99% YoY and by 49% QoQ
The company's net income has surged by 64% YoY and by 32% QoQ
The operating income has soared by 58% YoY and by 27% from the previous quarter

Growth

What is Wave Life Sciences's growth rate over time

Valuation

What is Wave Life Sciences stock price valuation
P/E
N/A
P/B
15.35
P/S
5.75
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.14
Wave Life Sciences's EPS has soared by 74% YoY and by 36% from the previous quarter
The equity has soared by 198% from the previous quarter and by 188% YoY
The P/S is 80% below the 5-year quarterly average of 28.1 and 56% below the last 4 quarters average of 13.0
Wave Life Sciences's revenue has increased by 33% QoQ

Efficiency

How efficient is Wave Life Sciences business performance
Wave Life Sciences's ROS has soared by 99% YoY and by 48% from the previous quarter
WVE's return on assets has surged by 74% year-on-year and by 41% since the previous quarter

Dividends

What is WVE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for WVE.

Financial health

How did Wave Life Sciences financials performed over time
The total assets is 21% greater than the total liabilities
The total assets has soared by 88% year-on-year and by 38% since the previous quarter
The total liabilities has grown by 24% YoY but it has contracted by 2.2% from the previous quarter
Wave Life Sciences's debt is 19% lower than its equity
Wave Life Sciences's debt to equity has soared by 198% from the previous quarter and by 198% YoY
The equity has soared by 198% from the previous quarter and by 188% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.